Behavioral Therapy Development for Methamphetamine Abuse

NCT00252434 | Terminated Phase 1

• 1 other identifier: 1R21DA018075
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to evaluate whether a specially developed group counseling approach is better able to help HIV-positive gay and bisexual men (GBM) who use crystal meth to stop using methamphetamines, reduce sexual risk behaviors, and stay on their HIV medications than a standard drug treatment program. Another purpose is to determine whether having a drug abuse treatment program in an HIV medical clinic makes it easier to attend treatment than going to a separate location for drug abuse treatment.

Conditions

Depression; Drug Abuse; Sexually Transmitted Diseases

Keywords

high-risk sexual behavior; methamphetamine use; drug craving; addiction behaviors

Outcome Measures

Primary Outcomes (1)

• methamphetamine use

  weekly

Secondary Outcomes (1)

• sexual risk behaviors

  monthly

Interventions

Cognitive Behavioral Therapy Development for Methamphetamine Abuse BEHAVIORAL

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: male
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the University of California, Los Angeles (UCLA) Center for Clinical AIDS Research and Education (CARE) clinic, aged 18-65
• Willing to give informed consent and comply with study procedures
• Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications
• Diagnosed with current methamphetamine abuse as determined by Mini-International Neuropsychiatric Interview (MINI)
• Interested in seeking treatment for methamphetamine abuse and in participating in this research project.

You may not qualify if:

• Unwilling to give, or withdrawal of, informed consent
• Inability to understand nature of study
• A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision \[DSM-IV-TR\] criteria for current bipolar disorder or a psychotic disorder)
• Current suicidal ideation or suicide attempt within the past 3 months
• Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.
• Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.

Sponsors & Collaborators

• University of California, Los Angeles: lead

Study Sites (1)

UCLA Center for Clinical AIDS Research and Education (CARE) Clinic

Los Angeles, California, 90035, United States

Location

MeSH Terms

Conditions

Depression; Substance-Related Disorders; Sexually Transmitted Diseases

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Chemically-Induced Disorders; Mental Disorders; Communicable Diseases; Infections; Genital Diseases; Urogenital Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• James A. Peck, PsyD.

  UCLA Integrated Substance Abuse Programs

  PRINCIPAL INVESTIGATOR

• James A Peck, Psy.D.

  UCLA Integrated Substance Abuse Programs

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 1
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: November 10, 2005
• First Posted: November 11, 2005
• Study Start: August 1, 2004
• Primary Completion: November 1, 2007
• Study Completion: November 1, 2007
• Last Updated: January 27, 2016

Record last verified: 2016-01

Locations

US (1)